Systematic evaluation of economic evaluations of Nivolumab and Pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
DU Yi, YANG Fan, JIANG Rong, SHEN Jian, SHAO Rong
Chinese Journal of Hospital Pharmacy ›› 2024, Vol. 44 ›› Issue (4) : 441-446.
Systematic evaluation of economic evaluations of Nivolumab and Pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |